Hero Graphic Fda

Medical Device Regulatory Submissions

Get Approved Faster—Without the Back-and-Forth

Regulatory submissions are where most medical device companies lose time.

Not because their technology isn’t strong—but because their submission isn’t aligned with what regulators expect.

At RQMIS, we don’t just prepare submissions—we build, position, and defend them so you can move through the approval process with confidence and speed.

The Reality: Submissions Fail More Often Than They Should

Many companies run into delays because of:

  • Incomplete or poorly structured submissions
  • Misalignment between testing, claims, and regulatory expectations
  • Weak responses to regulatory questions
  • Lack of strategy during interactions with FDA or Notified Bodies

The result? Deficiency letters, rework, and months of delay.

What We Do

RQMIS delivers end-to-end regulatory submission support—from early planning through approval and beyond.

We start by making sure you’re building the right submission—not just a complete one.

  • Selection of optimal pathway (510(k), De Novo, PMA, CE Mark)
  • Alignment of testing, clinical evidence, and claims
  • Early identification of risks that could delay approval

By addressing these factors upfront, we help you avoid costly redesigns and regulatory setbacks.

Submission Preparation & Authoring

We prepare submissions that are clear, complete, and reviewer-friendly.

  • 510(k), De Novo, PMA, and global submissions
  • Technical documentation and dossiers
  • Clinical and preclinical evidence integration
  • Labeling, Intended Use, and claims alignment

Our focus: eliminate ambiguity so reviewers can evaluate—and approve—your submission efficiently.

Regulatory Interaction & Negotiation

Approval isn’t just about what you submit—it’s about how you engage.

  • FDA Pre-Submissions and meeting support
  • Direct interaction with regulatory authorities
  • Strategic positioning of your data and claims

Our team includes former FDA reviewers, giving us insight into how decisions are actually made—and how to navigate them effectively.

Deficiency Letter & Submission Repair

If your submission hits a roadblock, we help you recover—fast.

  • Interpretation of FDA or Notified Body feedback
  • Gap analysis and root cause identification
  • Strategic response development
  • Rewriting and resubmission support

We don’t just respond—we fix the underlying issues to get your submission back on track.

Commercial & Market Alignment

Approval is only part of the equation.

We ensure your submission supports long-term success:

  • Claims that are both compliant and marketable
  • Labeling aligned with commercial strategy
  • Clinical strategy that supports reimbursement

Because getting cleared is step one—getting adopted is what matters next.

A Smarter Way to Approach Submissions

Most companies treat regulatory submissions as a documentation exercise.

That’s a mistake.

Successful submissions require:

  • Alignment between product, data, and claims
  • Anticipation of reviewer concerns
  • Strategic communication—not just compliance

RQMIS brings all three together.

The Outcome

With RQMIS, you can:

  • Reduce review cycles and regulatory delays
  • Avoid costly rework and resubmissions
  • Navigate regulatory interactions with confidence
  • Accelerate time to market

Why RQMIS

  • Experience across FDA, EU MDR, and global submissions
  • Former FDA reviewer insight
  • Integrated regulatory, clinical, and quality expertise
  • Proven ability to repair and accelerate stalled submissions

We don’t just help you submit—we help you get approved.

Ready to Move Your Submission Forward?

Whether you’re preparing your first submission or recovering from delays, RQMIS provides the expertise and execution to get you across the finish line.

Contact us to accelerate your regulatory submission strategy.

Click Here to Learn More